948 Results

People

  1. Kelsen
    Kelsen
  2. Kris
    Kris
  3. Kemeny
    Kemeny
  4. Scher
    Scher
  5. Heelan
    Heelan
  6. Saltz
    Saltz
  7. Bajorin
    Bajorin
  8. Bosl
    Bosl
  9. Casper
    Casper
  10. Gralla
    Gralla

Groups

  1. Department of Medicine (389)
  2. Solid Tumor Oncology Division (295)
  3. Sloan Kettering Institute Faculty (141)
  4. Gastrointestinal Oncology Service (120)
  5. Survivorship Research (116)
  6. Molecular Pharmacology and Chemistry Program Faculty (107)
  7. Surgery (102)
  8. Nursing (87)
  9. Center for Pancreatic Cancer Research (80)
  10. GSK Faculty (80)
  1. "intravenous drug administration"
Formats
  1. Journal Article (883)
  2. Conference Paper (54)
  3. Review (7)
  4. Meeting Abstract (2)
  5. Guidelines (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (389)
  2. Solid Tumor Oncology Division (295)
  3. Sloan Kettering Institute Faculty (141)
  4. Gastrointestinal Oncology Service (120)
  5. Survivorship Research (116)
  6. Molecular Pharmacology and Chemistry Program Faculty (107)

More Groups

People
  1. David Kelsen (73)
  2. Mark Kris (55)
  3. Nancy Kemeny (49)
  4. George Bosl (40)
  5. Howard Scher (38)
  6. Robert Heelan (37)

More People

Years
  1. 2025 (1)
  2. 2024 (8)
  3. 2023 (3)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (109)
  2. Cancer (86)
  3. Cancer Treatment Reports (35)
  4. Seminars in Oncology (29)
  5. Cancer Research (26)
  6. Cancer Investigation (20)

More Publications

Publishers
  1. Elsevier Inc. (111)
  2. American Society of Clinical Oncology (109)
  3. Wiley Blackwell (104)
  4. Lippincott Williams & Wilkins (85)
  5. Springer (75)
  6. American Association for Cancer Research (41)

More Publishers

Results (948)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 3 trial of Ibrutinib plus rituximab in Waldenström's macroglobulinemia
    Journal Article

    Dimopoulos, M. A.; Tedeschi, A.; Trotman, J.; García-Sanz, R.; Macdonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C.; Orsucci, L.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Selective nanoparticle targeting of the renal tubules
    Journal Article

    Williams, R. M.; Shah, J.; Tian, H. S.; Chen, X.; Geissmann, F.; Jaimes, E. A.; Heller, D. A.
    Hypertension (2018)

    Fulltext@MSK | Save
  • Treatment of patients with metastatic cancer using a major histocompatibility complex class II-restricted T-cell receptor targeting the cancer germline antigen MAGE-A3
    Journal Article

    Lu, Y. C.; Parker, L. L.; Lu, T.; Zheng, Z.; Toomey, M. A.; White, D. E.; Yao, X.; Li, Y. F.; Robbins, P. F.; Feldman, S. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II trial of atezolizumab as first-line or subsequent therapy for patients with programmed death-ligand 1-selected advanced non-small-cell lung cancer (BIRCH)
    Journal Article

    Peters, S.; Gettinger, S.; Johnson, M. L.; Jänne, P. A.; Garassino, M. C.; Christoph, D.; Toh, C. K.; Rizvi, N. A.; Chaft, J. E.; Costa, E. C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Efficacy and safety of nivolumab in patients with BRAF V600 mutant and BRAF wild-type advanced melanoma: A pooled analysis of 4 clinical trials
    Journal Article

    Larkin, J.; Lao, C. D.; Urba, W. J.; McDermott, D. F.; Horak, C.; Jiang, J.; Wolchok, J. D.
    JAMA Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies
    Journal Article

    von Mehren, M.; Bookman, M.; Meropol, N. J.; Weiner, L. M.; Sherman, E.; Li, J.; Knoblauch, R.; Parekh, T.; Cohen, R. B.
    Cancer Chemotherapy and Pharmacology (2015)

    Fulltext@MSK | Save
  • A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer
    Journal Article

    Suidan, R. S.; St. Clair, C. M.; Lee, S. J.; Barlin, J. N.; Long Roche, K. C.; Tanner, E. J.; Sonoda, Y.; Barakat, R. R.; Zivanovic, O.; Chi, D. S.
    Gynecologic Oncology (2014)

    Fulltext@MSK | Save
  • Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia
    Journal Article

    Douer, D.; Aldoss, I.; Lunning, M. A.; Burke, P. W.; Ramezani, L.; Mark, L.; Vrona, J.; Park, J. H.; Tallman, M. S.; Avramis, V. I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase i study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma
    Journal Article

    Patel, P. H.; Senico, P. L.; Curiel, R. E.; Motzer, R. J.
    Clinical Genitourinary Cancer (2009)

    Fulltext@MSK | Save
  • Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors
    Journal Article

    Ku, G. Y.; O'Reilly, E. M.; Saltz, L. B.; Schrag, D.; Maki, R. G.; Kelsen, D. P.; Ilson, D. H.
    Cancer Investigation (2009)

    Fulltext@MSK | Save